Saturday 17 October 2026
Export NRC’s income statement to Excel — free account
National Research Corporation
NRC Healthcare Health Information Services
National Research Corporation’s revenue for fiscal 2025 (year ended December 2025) was $137.4 million, down 3.96% from fiscal 2024. In the quarter to June 2026, revenue grew 3.98%, EPS fell 3,091.5%, free cash flow grew 101.5% and total debt rose 11.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years; insiders bought in the last twelve months.
20.15
0.96
−4.55%
Follow NRC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
66.87% | 49.88% | 40.43% | 39.82% | |
Piotroski F-Score |
6 | 6 | 5 | 5 | |
| 12.23% | 8.45% | 6.47% | 4.00% | ||
ROIC |
19.51% | 16.64% | 14.39% | 10.32% | |
Return on Tangible Assets |
70.38% | 46.93% | 40.00% | 20.34% | |
Average Days of Receivables |
33.45 | 30.91 | 29.79 | 35.59 | |
Free Cash Flow per Share |
0.53 | 0.70 | 0.80 | 0.98 | |
Free Cash Flow |
11.62 | 15.74 | 17.43 | 21.64 | |
Capital Expenditures |
(14.03) | (10.71) | (9.55) | (7.87) | |
| Other line items | |||||
Cash ROIC |
12.56% | 16.90% | 19.35% | 22.57% | |
Accounts Receivable Turnover |
11.38 | 12.04 | 12.17 | 10.56 | |
Accounts Payable Turnover |
28.67 | 44.33 | 24.88 | 42.74 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
7.56 | 8.15 | 15.35 | 9.04 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.30) | (0.35) | (0.38) | (0.38) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
37.25% | 39.89% | 41.74% | 45.06% | |
Share Based Compensation of Revenue |
1.14% | 2.41% | 3.43% | 8.44% | |
Interest Coverage |
6.68 | 4.74 | 3.82 | 2.73 | |
Operating CF/Net income |
1.57 | 2.34 | 3.09 | 5.32 | |
Depreciation/Fixed assets |
0.17 | 0.19 | 0.21 | 0.22 | |
Capex/Depreciation |
(1.98) | (1.39) | (1.14) | (0.90) | |
Revenue per Share |
6.29 | 6.14 | 6.36 | 6.36 | |
Operating CF per Share |
1.16 | 1.18 | 1.24 | 1.34 | |
Capex per Share |
(0.63) | (0.48) | (0.44) | (0.36) | |
Capex to Sales |
0.10 | 0.08 | 0.07 | 0.06 |
Columns are period end dates